NCT07787806

Brief Summary

This is a randomized controlled, type 1 hybrid effectiveness-implementation trial to evaluate the effectiveness of a patient-reported outcomes (PRO)-driven culturally grounded supportive care navigation in reducing healthcare disparities among Hispanic/Latinx patients receiving anticancer therapies. The objectives of this study are: (1) to compare the effectiveness of an ePRO-driven culturally grounded supportive care navigation versus usual care (control) in Hispanic/Latinx patients undergoing anticancer treatment; and (2) to elicit perspectives from Hispanic/Latinx patients, healthcare providers, and community partners on how an ePRO-driven culturally grounded supportive care navigation can address health disparities.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
26mo left

Started Nov 2026

Typical duration for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 22, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 26, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2026

Expected
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

August 26, 2026

Status Verified

August 1, 2026

Enrollment Period

1.2 years

First QC Date

August 22, 2026

Last Update Submit

August 22, 2026

Conditions

Keywords

patient navigationpatient-reported outcomessupportive care in cancercancer survivorship

Outcome Measures

Primary Outcomes (1)

  • ED visits, hospitalizations, and urgent care visits

    Detailed information regarding ED visits, hospitalization, and urgent care visits from the first 3 months of anticancer treatment (after joining the study) will be obtained using EMR, and the UCI Health Data Warehouse.

    baseline and 3 months post-baseline

Secondary Outcomes (3)

  • Health-related quality of life

    baseline and 3 months post-baseline

  • Symptom severity

    baseline and 3 months post-baseline

  • Health literacy

    baseline and 3 months post-baseline

Other Outcomes (1)

  • Inflammatory biomarkers

    baseline and 3 months post-baseline

Study Arms (2)

Usual care

NO INTERVENTION

Patient-Reported Outcomes (PRO)-driven supportive care navigation

EXPERIMENTAL
Other: Patient-Reported Outcomes (PRO)-driven supportive care navigation

Interventions

Patients within the intervention arm will receive ePRO-driven supportive care navigation consisting of: (1) routine distress screening and care needs assessment; (2) machine learning-based acute care utilization risk prediction; (3) culturally grounded supportive care navigation; and (4) community follow-up.

Patient-Reported Outcomes (PRO)-driven supportive care navigation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least 18 years old
  • Hispanic/LatinX origin
  • Newly diagnosed cancer patients
  • Receiving anticancer treatment (may include combinations of intravenous or oral chemotherapy, targeted therapies, and/or immunotherapies)

You may not qualify if:

  • Being physically and/or mentally incapable of providing written consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chao Family Comprehensive Cancer Center

Irvine, California, 92617, United States

Location

Related Publications (17)

  • Velikova G, Booth L, Smith AB, Brown PM, Lynch P, Brown JM, Selby PJ. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol. 2004 Feb 15;22(4):714-24. doi: 10.1200/JCO.2004.06.078.

    PMID: 14966096BACKGROUND
  • Kotronoulas G, Kearney N, Maguire R, Harrow A, Di Domenico D, Croy S, MacGillivray S. What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol. 2014 May 10;32(14):1480-501. doi: 10.1200/JCO.2013.53.5948. Epub 2014 Apr 7.

    PMID: 24711559BACKGROUND
  • Basch E, Barbera L, Kerrigan CL, Velikova G. Implementation of Patient-Reported Outcomes in Routine Medical Care. Am Soc Clin Oncol Educ Book. 2018 May 23;38:122-134. doi: 10.1200/EDBK_200383.

    PMID: 30231381BACKGROUND
  • Cheung YT, Chan A, Charalambous A, Darling HS, Eng L, Grech L, van den Hurk CJG, Kirk D, Mitchell SA, Poprawski D, Rammant E, Ramsey I, Fitch MI, Chan RJ. The use of patient-reported outcomes in routine cancer care: preliminary insights from a multinational scoping survey of oncology practitioners. Support Care Cancer. 2022 Feb;30(2):1427-1439. doi: 10.1007/s00520-021-06545-7. Epub 2021 Sep 15.

    PMID: 34524527BACKGROUND
  • Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, Mendoza TR, Hay J, Atkinson TM, Abernethy AP, Bruner DW, Cleeland CS, Sloan JA, Chilukuri R, Baumgartner P, Denicoff A, St Germain D, O'Mara AM, Chen A, Kelaghan J, Bennett AV, Sit L, Rogak L, Barz A, Paul DB, Schrag D. Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014 Sep 29;106(9):dju244. doi: 10.1093/jnci/dju244. Print 2014 Sep.

    PMID: 25265940BACKGROUND
  • Wagner LI, Schink J, Bass M, Patel S, Diaz MV, Rothrock N, Pearman T, Gershon R, Penedo FJ, Rosen S, Cella D. Bringing PROMIS to practice: brief and precise symptom screening in ambulatory cancer care. Cancer. 2015 Mar 15;121(6):927-34. doi: 10.1002/cncr.29104. Epub 2014 Nov 6.

    PMID: 25376427BACKGROUND
  • Chan RJ, Milch VE, Crawford-Williams F, Agbejule OA, Joseph R, Johal J, Dick N, Wallen MP, Ratcliffe J, Agarwal A, Nekhlyudov L, Tieu M, Al-Momani M, Turnbull S, Sathiaraj R, Keefe D, Hart NH. Patient navigation across the cancer care continuum: An overview of systematic reviews and emerging literature. CA Cancer J Clin. 2023 Nov-Dec;73(6):565-589. doi: 10.3322/caac.21788. Epub 2023 Jun 26.

    PMID: 37358040BACKGROUND
  • Alvidrez J, Castille D, Laude-Sharp M, Rosario A, Tabor D. The National Institute on Minority Health and Health Disparities Research Framework. Am J Public Health. 2019 Jan;109(S1):S16-S20. doi: 10.2105/AJPH.2018.304883.

    PMID: 30699025BACKGROUND
  • Santos Salas A, Fuentes Contreras J, Armijo-Olivo S, Saltaji H, Watanabe S, Chambers T, Walter L, Cummings GG. Non-pharmacological cancer pain interventions in populations with social disparities: a systematic review and meta-analysis. Support Care Cancer. 2016 Feb;24(2):985-1000. doi: 10.1007/s00520-015-2998-9. Epub 2015 Nov 10.

    PMID: 26556211BACKGROUND
  • Duma N, Velazquez AI, Franco I, Kiel L, Levit LA, Schenkel C, Kirkwood K, Green S, Rodriguez G. Donde Estan? Latinx/Hispanic Representation in the Oncology Workforce: Present and Future. JCO Oncol Pract. 2022 May;18(5):388-395. doi: 10.1200/OP.22.00153.

    PMID: 35544646BACKGROUND
  • Seible DM, Kundu S, Azuara A, Cherry DR, Arias S, Nalawade VV, Cruz J, Arreola R, Martinez ME, Nodora JN, Rahn DA, Murphy JD. The Influence of Patient-Provider Language Concordance in Cancer Care: Results of the Hispanic Outcomes by Language Approach (HOLA) Randomized Trial. Int J Radiat Oncol Biol Phys. 2021 Nov 15;111(4):856-864. doi: 10.1016/j.ijrobp.2021.05.122. Epub 2021 May 29.

    PMID: 34058256BACKGROUND
  • Cooper LA, Roter DL, Johnson RL, Ford DE, Steinwachs DM, Powe NR. Patient-centered communication, ratings of care, and concordance of patient and physician race. Ann Intern Med. 2003 Dec 2;139(11):907-15. doi: 10.7326/0003-4819-139-11-200312020-00009.

    PMID: 14644893BACKGROUND
  • Martinez KA, Snyder CF, Malin JL, Dy SM. Is race/ethnicity related to the presence or severity of pain in colorectal and lung cancer? J Pain Symptom Manage. 2014 Dec;48(6):1050-9. doi: 10.1016/j.jpainsymman.2014.02.005. Epub 2014 Apr 18.

    PMID: 24747225BACKGROUND
  • Reyes-Gibby CC, Anderson KO, Shete S, Bruera E, Yennurajalingam S. Early referral to supportive care specialists for symptom burden in lung cancer patients: a comparison of non-Hispanic whites, Hispanics, and non-Hispanic blacks. Cancer. 2012 Feb 1;118(3):856-63. doi: 10.1002/cncr.26312. Epub 2011 Jul 12.

    PMID: 21751190BACKGROUND
  • Duran DG, Perez-Stable EJ. Novel Approaches to Advance Minority Health and Health Disparities Research. Am J Public Health. 2019 Jan;109(S1):S8-S10. doi: 10.2105/AJPH.2018.304931. No abstract available.

    PMID: 30699017BACKGROUND
  • John DA, Kawachi I, Lathan CS, Ayanian JZ. Disparities in perceived unmet need for supportive services among patients with lung cancer in the Cancer Care Outcomes Research and Surveillance Consortium. Cancer. 2014 Oct 15;120(20):3178-91. doi: 10.1002/cncr.28801. Epub 2014 Jul 1.

    PMID: 24985538BACKGROUND
  • Chan A, Ng DQ, Arcos D, Heshmatipour M, Lee BJ, Chen A, Duong L, Van L, Nguyen T, Green V, Hoang D. Electronic Patient-Reported Outcome-Driven Symptom Management by Oncology Pharmacists in a Majority-Minority Population: An Implementation Study. JCO Oncol Pract. 2024 Dec;20(12):1744-1754. doi: 10.1200/OP.24.00050. Epub 2024 Jul 15.

    PMID: 39008806BACKGROUND

MeSH Terms

Conditions

Neoplasms

Interventions

Patient Reported Outcome Measures

Intervention Hierarchy (Ancestors)

Health Care SurveysSurveys and QuestionnairesData CollectionEpidemiologic MethodsInvestigative TechniquesHealth Services ResearchHealth PlanningHealth Care Economics and OrganizationsPatient Outcome AssessmentOutcome Assessment, Health CareOutcome and Process Assessment, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and EvaluationHealth Care Evaluation MechanismsPublic HealthEnvironment and Public Health

Study Officials

  • Alexandre Chan, PharmD, PhD, MPH

    University of California, Irvine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Fan-Ying Chan, MS

CONTACT

Matthew Heshmatipour, MPH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Clinical Pharmacy

Study Record Dates

First Submitted

August 22, 2026

First Posted

August 26, 2026

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2028

Last Updated

August 26, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations